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It has been widely reported that b-amyloid peptide
(Ab) blocks long-term potentiation (LTP) of hippo-
campal synapses. Here, we show evidence that Ab
more potently blocks the potentiation of excitatory
postsynaptic potential (EPSP)-spike coupling (E-S
potentiation). This occurs, not by direct effect on
excitatory synapses or postsynaptic neurons, but
rather through an indirect mechanism: reduction of
endocannabinoid-mediated peritetanic disinhibition.
During high-frequency (tetanic) stimulation, somatic
synaptic inhibition is suppressed by endocannabi-
noids. We find that Ab prevents this endocannabi-
noid-mediated disinhibition, thus leaving synaptic
inhibition more intact during tetanic stimulation.
This intact inhibition opposes the normal depolariza-
tion of hippocampal pyramidal neurons that occurs
during tetanus, thus opposing the induction of syn-
aptic plasticity. Thus, a pathway through which Ab
can act to modulate neural activity is identified, rele-
vant to learning and memory and how it maymediate
aspects of the cognitive decline seen in Alzheimer’s
disease.
INTRODUCTION
Alzheimer’s disease (AD), a progressive neurodegenerative dis-
order typically affecting the elderly, is characterized clinically by
cognitive decline leading to severe impairment and eventually
death. Studies show that it is associated with key pathologies
termed beta amyloid plaques and neurofibrillary tangles, as
well as a severe loss of neurons and brain volume. Studies in
both human patients and animalmodels of ADpoint to overaccu-
mulation of soluble oligomers of b-amyloid peptide (Ab) as
a mediator of learning and memory impairments early in the1334 Neuron 82, 1334–1345, June 18, 2014 ª2014 Elsevier Inc.disease (for review, see Hoe et al., 2012; Rowan et al., 2005;
Selkoe, 2008).
In this context, the effects of Ab on long-term potentiation
(LTP) of synaptic transmission have been widely studied. LTP
is the persistent increase in the strength of synaptic transmission
that occurs at synapses that have been briefly activated at high
frequency (e.g., 100 Hz for 1 s). It remains the most compelling
model for a learning mechanism at the synaptic level (Bliss and
Collingridge, 1993). In general, application of submicromolar
concentrations of Ab to hippocampal tissue has been reported
to result in a reduction in LTP (Chen et al., 2000; Cullen et al.,
1997; Freir et al., 2001; Gengler et al., 2007; Kim et al., 2013;
Klyubin et al., 2004; Kroker et al., 2013; Lambert et al., 1998;
Nomura et al., 2005, 2012; Rammes et al., 2011; Raymond
et al., 2003; Ro¨nicke et al., 2008; Rowan et al., 2004; Townsend
et al., 2006; Vitolo et al., 2002; Walsh et al., 2002; Wang et al.,
2002, 2004b) leading to speculation that this is a critical path
by which Ab may impair learning and/or memory.
In our initial studies on the effects of Ab, we noted that this
amyloid peptide seemed to be much more effective in blocking
potentiation of the hippocampal population spike than it was
blocking LTP of synaptic transmission. This suggested that a pri-
mary effect of Ab might be to block potentiation of EPSP-spike
coupling, or E-S potentiation. E-S potentiation is another form
of activity-dependent potentiation that is induced concurrently
with synaptic LTP. It is a strengthening of the apparent electrical
coupling between the dendritic synaptic inputs and the soma,
such that a greater proportion of the EPSP survives at the spike
trigger zone, resulting in greater action potential output for a
given synaptic input (Abraham et al., 1985; Bliss and Lomo,
1973; Chavez-Noriega et al., 1989; Daoudal and Debanne,
2003; Hanse, 2008; Jester et al., 1995; Taube and Schwartz-
kroin, 1988; Wilson, 1981). This potentiation of EPSP-spike
(E-S) coupling provides an additional boost to the efficacy of
the EPSP on top of the potentiation (LTP) that occurs at the syn-
apse (Bliss and Lomo, 1973). In essence, LTP makes the EPSP
larger, and E-S potentiation makes a greater proportion of that
EPSP survive to the spike trigger zone at the axon hillock.
Figure 1. Ab1–42 Impairs E-S Potentiation
and LTP
(A) Schematic diagram of a hippocampal slice
illustrating the placement of electrodes used in
these experiments. The stimulating electrode was
placed in the stratum radiatum, near the CA2/CA1
border. Two recording electrodes were place in
mid-CA1, one in s. radiatum (1) to record field
excitatory postsynaptic potentials (fEPSP) and
one in s. pyramidale (2) to record field population
spikes. S.c., Schaffer collaterals.
(B) LTP of the fEPSP, following a weak inducing
stimulus ([, five bursts of four stimuli at 100 Hz,
400 ms interburst interval) is reduced by Ab1–42
(B, n = 7; 105% ± 5%) compared to vehicle
(C; n = 7; 115% ± 4%) (p < 0.01 at 35–40 min
posttetanus).
(C) LTP of the fEPSP resulting from a strong
inducing stimulus (Y, tetanus; three 1 s duration
100 Hz trains of stimuli delivered 15 s apart) is
not significantly reduced by Ab1–42 (B, n = 7;
129% ± 6%) compared to vehicle (C; n = 7;
146% ± 13%; p = 0.375, n.s. not significant).
(D) LTP of population spikes recorded concur-
rently with the EPSPs in part C is strongly reduced
by treatment with Ab1–42 (B, n = 7; 320%± 55%)
compared to vehicle (C; n = 7; 555% ± 74%)
(p = 0.036).
(E) Potentiation of E-S coupling (E-S potentiation)
is impaired by Ab1–42 (B, n = 7; 242% ± 36%)
compared to vehicle (C; n = 7; 379% ± 41%)
(p = 0.024). E-S coupling is expressed as the ratio
of population spike area to fEPSP rising slope (i.e.,
the data in D and C).
(F) Application of Ab1–42 has no effect on the
rising slope of the fEPSP (top), the area of the
population spike (middle), or the E-S coupling
(bottom); all three recorded simultaneously. The
solid bar indicates the time of application of Ab1–42 and applies to all three panels, all of which are reported as percent of baseline. All insets show exemplar
traces from slices treated with vehicle (0.001%NH4OH) or Ab1–42 in vehicle beginning 20 min before LTP induction. The numerals near the traces correspond to
the times indicated by the same numerals in the graphs. Potentiation, compared to baseline, was statistically significant at p < 0.01 in all cases in (B–E), over the
entire posttetanus range by 2-way ANOVA for repeated-measures. All error bars and quantification in this figure reflect mean ± SEM.
See also Figure S1.
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Ab Inhibits Endocannabinoid-Mediated DisinhibitionAlthough LTP and E-S potentiation are mechanistically distinct
processes, they may share some features besides the fact that
both are induced by high-frequency synaptic activation. There
is some evidence that E-S potentiation may in some circum-
stances require activation of the NMDA-receptor (Breakwell
et al., 1996; Jester et al., 1995), although others have reported
no involvement of this receptor (Bernard andWheal, 1995a; Ray-
mond et al., 2003). Activation of a metabotropic glutamate
receptor has also been implicated (Breakwell et al., 1996). Like
LTP, E-S potentiation is strongly influenced by the state of
GABAergic synaptic inhibition, with stronger inhibition opposing
E-S potentiation (Bernard and Wheal, 1995b; Chavez-Noriega
et al., 1989; Daoudal et al., 2002; Staff and Spruston, 2003;
Tomasulo et al., 1991). Whether the influence of GABAergic
transmission is limited to the induction of E-S potentiation, or
is also involved in its expression remains an open question
(Chavez-Noriega et al., 1990; Jester et al., 1995; Kairiss et al.,
1987). In this paper, we examine the effects of Ab on E-S
potentiation and reveal a signaling mechanism for this amyloidpeptide involving the suppression of endocannabinoid-mediated
peritetanic disinhibition during the induction of LTP and E-S
potentiation.
RESULTS
While attempting to replicate the previously reported suppres-
sion of LTP by Ab (Ab1–42) using extracellular field potential
recording in stratum radiatum of area CA1 in hippocampal slices
(see Figure 1A), we noted that LTP was suppressed only
modestly by bath application of Ab1–42 (500 nM), most promi-
nently when a ‘‘weak’’ inducing stimulus (five bursts of four stim-
uli with 400 ms interburst intervals) (Figure 1B) and to a lesser
amount when a ‘‘strong’’ tetanic induction protocol (three 1 s
duration trains at 100 Hzwith intertrain interval of 15 s) (Figure 1C
and Figure S1 available online) was used to induce plasticity.
However, upon closer examination, we noticed that Ab strongly
altered the tetanus-induced change in the population spike.
This suggested to us that the main effect of Ab might be onNeuron 82, 1334–1345, June 18, 2014 ª2014 Elsevier Inc. 1335
Figure 2. Ab1–42 Has No Effect on E-S
Potentiation when Applied after Tetanic
Stimulation
(A–C) Time course for change in signal following
tetanic stimulation (Y) for slices treated with
500 nM synthetic Ab1–42 (B; n = 5) or vehicle
(C; n = 5). When applied beginning 5 min after
the tetanus, Ab1–42 does not impair potentiation
of (A) fEPSP initial slope (Ab1–42:B; 138% ± 5%,
vehicle: C; 139% ± 8%) (p = 0.701), (B)
population spike area (Ab1–42:B; 500% ± 36%,
vehicle:C; 518% ± 59%) (p = 0.726), or (C) E-S
coupling (Ab1–42: B; 364% ± 30%, vehicle: C;
381% ± 53%) (p = 0.754). Insets for (A) and (B):
exemplar fEPSPs (A) or Population spikes (B) from
vehicle (left) and Ab1–42 (right)-treated slices. The
numerals 1 and 2 on the graph indicate the times
at which the corresponding inset traces were re-
corded.
(D) Comparison of E-S potentiation at 35–40 min
posttetanus when Ab1–42 was applied beginning
20 min before that tetanus (as in Figure 1) or
beginning 5 min after the tetanus (as in A–C).
Ab1–42 application after tetanic stimulation has
no effect on potentiation (Ab1–42, white bars;
vehicle, black bars). All error bars and quantifi-
cation in this figure reflect mean ± SEM.
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Ab Inhibits Endocannabinoid-Mediated Disinhibitionpotentiation of the coupling between the EPSP and somatic ac-
tion potential rather than on synaptic transmission itself and led
us to examine the effects of Ab on E-S potentiation. E-S poten-
tiation is induced by the same tetanic stimuli as LTP and so is
generally coexpressed with LTP (Abraham et al., 1985; Bliss
and Lomo, 1973; Chavez-Noriega et al., 1989; Taube and
Schwartzkroin, 1988; Wilson, 1981; Wilson et al., 1981). To mea-
sure E-S coupling and potentiation of that coupling, we
compared stimulus-evoked synaptic transmission via the field
EPSP (fEPSP) (Figure 1C) with the simultaneously recorded
action potential discharge of the postsynaptic neurons via the
population spike (Figure 1D). The ratio of population spike area
and the fEPSP rising slope give a measure of E-S coupling (Fig-
ure 1E). In these experiments, LTP and E-S potentiation were
induced by application of the strong tetanic stimulation protocol.
On average, in the experiments illustrated in Figure 1, this pro-
duced 146% (±13%) potentiation of the fEPSP (Figure 1C)
and a 555% (±74%) potentiation of population spike area in
untreated slices (Figure 1D). This outsized increase in the popu-
lation spike does not simply represent a nonunity or nonlinearity
in the E-S coupling between the EPSP and the population spike,
but rather includes E-S potentiation, because decreasing the
stimulus to reduce the fEPSP back to its baseline size still pro-
duced a population spike greater than control (not shown). While
application of 500 nM of synthetic Ab1–42 peptide, beginning
20 min before tetanic stimulation, caused no significant reduc-
tion in the potentiation of the fEPSP slope (Figure 1C), it did
significantly reduce potentiation of the population spike (Fig-
ure 1D) and thus, reduced E-S potentiation (Figure 1E). Note
that Ab had no effect on basal, nonpotentiated fEPSPs, popula-
tion spikes or E-S coupling (Figure 1F). In most series of experi-
ments done for this paper, there was a trend toward less LTP in
the presence of Ab, but this apparent trend never reached a level1336 Neuron 82, 1334–1345, June 18, 2014 ª2014 Elsevier Inc.of statistical significancewith an n value of experiments for which
robust changes in plasticity are generally detectable. Given the
strong evidence in the literature that Ab can reduce LTP, we
examined this trend further by combining all experiments done
during the course of this study where the effects of Ab were
compared to control. With this much larger cohort of experi-
ments, the effects of Ab on LTP just barely reached significance
(p = 0.0494, Figure S1). The effects on E-S potentiation were, on
the other hand, much more robust. Whereas Ab potently
impaired E-S potentiation when applied before plasticity induc-
tion, it had no effect on LTP of the fEPSP, population spike or
E-S potentiation when applied beginning immediately after
tetanic stimulation (Figures 2A–2C). These results indicate that
Ab impairs some mechanism during induction, but not mainte-
nance or expression of E-S potentiation. A comparison of E-S
potentiation (35–40 min after tetanus) with Ab applied before or
after the tetanic stimulation is shown in Figure 2D.
E-S coupling has been previously shown to be influenced
largely by two distinct factors: the intrinsic leakiness of the den-
drites and soma (Staff and Spruston, 2003) and synaptic inhibi-
tion (Bernard and Wheal, 1995a; Chavez-Noriega et al., 1989;
Daoudal et al., 2002; Staff and Spruston, 2003; Tomasulo
et al., 1991). Both factors shunt a portion of the synaptic current
generated in the dendrite across the membrane of the postsyn-
aptic neuron, reducing synaptically driven depolarization at
the spike trigger zone in the soma and axon hillock. To test for
a role of synaptic inhibition, we applied the GABAA receptor
open-channel blocker picrotoxin (50 mM) beginning 1 hr before
tetanic stimulation. Any potentiation of E-S coupling that occurs
in the presence of picrotoxin would be independent of GABAA
receptor-mediated processes.
Blockade of synaptic inhibition by picrotoxin alone caused an
increase in E-S coupling in agreement with numerous previous
Figure 3. GABAA Block Occludes Ab-Mediated Impairment of E-S
Potentiation
Slices were treated with 50 mM picrotoxin beginning 1 hr prior to tetanic
stimulation (Y). Ab1–42 does not impair potentiation of (A) fEPSP initial slope
(Ab1–42:B; n = 8, 150% ± 7%, vehicle:C; n = 6, 147% ± 9%) (p = 0.664), (B)
population spike area (Ab1–42:B; 399% ± 87%, vehicle: C; 404% ± 87%)
(p = 0.777), or (C) E-S coupling (Ab1–42:B; 269% ± 59%, vehicle:C; 267% ±
47%) (p = 0.964) (C; n = 8). Insets for (A) and (B): exemplar fEPSPs (A) and
population spikes (B) from vehicle (left) and Ab 1–42 (right)-treated slices. The
numerals near the traces correspond to the times indicated by the same
numerals in the graphs. All error bars and quantification in this figure reflect
mean ± SEM.
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Ab Inhibits Endocannabinoid-Mediated Disinhibitionpublications (Abraham et al., 1987; Chavez-Noriega et al., 1989;
Daoudal et al., 2002; Tomasulo et al., 1991; Wigstro¨m and Gus-
tafsson, 1985). Upon application of picrotoxin, the fEPSP rising
slope remained the same, but the population spike grew mark-
edly as expected (Wigstro¨m and Gustafsson, 1985). In order
to avoid saturation of the population spike upon subsequentpotentiation, the stimulus strength was decreased to match
the population spike area as closely as possible with control
values. Tetanization in the presence of picrotoxin resulted in
potentiation of the fEPSP that was no different than control,
but potentiation of the population spike was diminished
compared to control without picrotoxin (Figures 3A and 3B).
Thus, picrotoxin alone reduced the amount of E-S potentiation
(Figure 3C) presumably by occluding it.
Ab, applied in the presence of picrotoxin, had no further effect
on LTP of either the fEPSP (Figure 3A), the population spike (Fig-
ure 3B), or E-S potentiation (Figure 3C). Thus, the Ab-sensitive
suppression of population spike potentiation and the resulting
reduction in E-S potentiation seems to have been completely
occluded by the prior addition of picrotoxin, suggesting that it
is entirely mediated through an action associated with the
GABAA receptor. These results further suggest that there is no
effect of Ab on non-GABA-related factors that might participate
in E-S potentiation, such as dendritic ‘leakiness.’’While the exact
nature of the interaction between GABAergic mechanisms and
Ab was unclear at this point, the fact that they did interact sug-
gested that we should examine this relationship more directly.
To examine directly themechanism of this interaction between
Ab and synaptic inhibition, we observed the actions of Ab on
inhibitory postsynaptic potentials (IPSPs) recorded intracellu-
larly. Stimulus-evoked IPSPs were recorded using sharp-micro-
electrode intracellular recording of the membrane voltage of
CA1 pyramidal neurons. While Ab had no effect on amplitude
of baseline IPSPs (Figure 4D) or on postsynaptic resting mem-
brane potential (Figure 4E), it had a dramatic effect on IPSPs
recorded immediately following tetanic stimulation (Figure 4A).
In the absence of Ab, tetanic stimulation caused a transient
disinhibition, seen as a suppression of the IPSP in the first 1–
5 min after the tetanic stimulation, which recovered back to
near baseline level within 10 min. This transient disinhibition
was largely absent when tetanic stimulation was delivered in
the presence of Ab (Figure 4A).
Ab-sensitive posttetanic disinhibition was reminiscent of the
well-characterized phenomenon of depolarization-induced sup-
pression of inhibition (DSI) (Alger et al., 1996; Castillo et al.,
2012; Pitler and Alger, 1994; Wilson and Nicoll, 2001), which is
known to bemediated by endocannabinoids released from post-
synaptic pyramidal neurons acting on cannabinoid 1 receptors
(CB1Rs) present on inhibitory presynaptic terminals. DSI is trig-
gered by postsynaptic depolarization, so it seemed an intriguing
idea that tetanic depolarization of the postsynaptic cell would
trigger a similar cannabinoid releaseand thus, that theposttetanic
disinhibition we observed might also be cannabinoid-mediated.
To test this hypothesis, we applied 2 mMof AM251, an antagonist
and inverse agonist to the cannabinoid 1 receptor (CB1R), prior
to tetanization to see if it would block posttetanic disinhibition.
Like Ab, AM251 application did prevent posttetanic disinhibition
(Figure4B).Whereascontrol slicesagain showed robust suppres-
sion of inhibition immediately following tetanus, those pretreated
with AM251 showed no posttetanic disinhibition (Figure 4B).
Thus, it appears that Ab suppresses posttetanic disinhibition
that is mediated through endocannabinoid receptor, CB1R.
If this blockade of disinhibition occurs not just following but
during the tetanic stimulation, it would be expected to influenceNeuron 82, 1334–1345, June 18, 2014 ª2014 Elsevier Inc. 1337
Figure 4. Ab Impairs Peritetanic Suppres-
sion of IPSPs
(A) A transient suppression of stimulus-evoked
inhibitory postsynaptic potential (IPSP) follows
tetanic stimulation (arrow) in control slices (C;
n = 8) to 58% ± 10% of baseline (p = 0.0013), and
to 94%±5%of baseline at 25–30min posttetanus
(inhibition significantly suppressed (p = 0.021) for
at least 20 min posttetanus by 2-way ANOVA for
repeated-measures). Ab1–42 (B; n = 7), applied
beginning 20 min before tetanic stimulation,
reduces this posttetanic suppression of inhibition
to 93% ± 4% of baseline (p = 0.016), and 102% ±
3% of baseline at 25–30 min posttetanus
(p = 0.498 by two-way ANOVA for repeated
measures). The initial difference between control
and Ab1–42 is significant (p < 0.001) by paired
t test and the difference remains significant by
2-way ANOVA for repeated-measures for 17 min
posttetanus (p = 0.049; difference across 20 min
p = 0.061). Inset: exemplar IPSPs from vehicle
(left) and Ab 1–42 (right)-treated slices, and control
(left) and AM251 (right). The numerals near the
traces correspond to the times indicated by the
same numerals in the graphs.
(B) AM251 (2 mM) applied 1 hr before tetanic
stimulation prevents tetanus-induced suppres-
sion of inhibition in a manner similar to Ab1–42. In
the presence of AM251, the IPSP was initially
suppressed to only 95% ± 10% of baseline (B;
n = 5, p = 0.204, n.s.), whereas controls saw
suppression to 50% ± 11% of baseline (C; n = 8;
p < 0.001). The difference between disinhibition in
control and AM251 conditions was significant by
paired t test for the first 7 min after tetanus
(p < 0.05), the difference over a 20 min span was
not significant by 2-way ANOVA for repeated-
measures (p = 0.142). Inset: exemplar IPSPs from
vehicle (left) and Ab 1–42 (right)-treated slices,
and control (left) and AM251 (right). The numerals near the traces correspond to the times indicated by the same numerals in the graphs.
(C) Averaged traces from intracellular CA1 pyramidal cell recordings during tetanic stimulation (three 1 s epochs of 100 Hz presynaptic electrical stimulation, 15 s
apart, third train illustrated). Action potentials appear blunted because of the averaging of traces. Slices were pretreated with vehicle (C; n = 7) or Ab1–42 (B;
n = 5 up to 500 ms, n = 4 for duration of trace).
(D and E) Application of Ab1–42 does not alter (D) the baseline amplitude of the IPSP (99% ± 2%;C; n = 8,B; n = 6, p = 0.333), or (E) the resting membrane
potential of pyramidal neurons (change in membrane potential (mV) at 0–3 min after HFS (vehicle:C; n = 7; 0.11 ± 0.8 mV; Ab1–42:B, n = 5; 0.18 ± 0.38 mV,
p = 0.415). All error bars and quantification in this figure reflect mean ± SEM.
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Ab Inhibits Endocannabinoid-Mediated Disinhibitionthe amount of postsynaptic depolarization that happens during
the tetanic induction of LTP and E-S potentiation. With inhibition
intact during tetanus (i.e., no disinhibition), there should be less
depolarization of the membrane potential during that tetanic
stimulation. Examination of the membrane potential of postsyn-
aptic neurons during tetanic stimulation revealed that Ab-treated
neurons underwent less depolarization during the tetanus than
did vehicle controls (Figure 4C). Indeed, in the presence of Ab,
membrane potentials were actually hyperpolarized during the
initial portion of the tetanic stimulation, while in the absence of
Ab, the membrane potential depolarized substantially during
the entire tetanic stimulation. Such a peritetanic suppression of
disinhibition, and thus a diminished depolarization during tetanic
stimulation, would be expected to blunt the induction of synaptic
plasticity (Gustafsson et al., 1987; Malinow and Miller, 1986).
If Abmediates its blockade of peritetanic disinhibition by inter-
rupting the action of the endocannabinoid pathway, then CB1R1338 Neuron 82, 1334–1345, June 18, 2014 ª2014 Elsevier Inc.antagonists should have the same effect on E-S potentiation as
Ab, and Ab should have no further effect in the presence of
CB1R antagonists. Previous work has shown that the CB1R
antagonist AM251 prevents E-S potentiation in a manner that
appears similar to our results with Ab (Chevaleyre and Castillo,
2003) and it has also been previously shown that endocannabi-
noid-mediated DSI was important in the for the induction of
LTP (Carlson et al., 2002). Therefore, we compared the effects
of AM251 on the E-S potentiation in the presence and absence
of Ab. AM251 (2 mM) alone produced little or no effect on LTP of
the fEPSP in our experiments (Figure 5A) although others have
shown more AM251 efficacy against LTP (Carlson et al., 2002).
AM251 did suppress potentiation of the population spike and
thus of E-S coupling (Figures 5B and 5C; see also Chevaleyre
and Castillo, 2003) in a manner identical to Ab (cf. Figures 1C–
1E). Application of Ab in the presence of AM251 produced no
additional reduction in potentiation of the fEPSP, the population
Figure 5. CB1RBlockadeOccludes Ab-Me-
diated Impairment of E-S Potentiation
(A–C) Effects of AM251 on LTP and E-S potentia-
tion. Tetanic stimulation (Y) results in potentiation
of (A) the fEPSP, (B) the simultaneously recorded
population spike, and (C) E-S coupling. Applica-
tion of AM251 beginning 1 hr before tetanic stim-
ulation did not significantly reduce potentiation of
the EPSP field compared to control (vehicle: C,
146%±12%, n = 6; AM251:B, 127%±5%, n = 6;
p = 0.088), but did reduce potentiation of the
population spike (vehicle:C, 947%±190%, n= 6;
AM251:B, 487% ± 65% n = 6; p = 0.022) and of
E-S coupling (vehicle: C, 621% ± 72%, n = 6;
AM251:B, 386% ± 54%, n = 6; p = 0.011 at 35–
40 min posttetanus). Insets for (A) and (B): exem-
plar fEPSP and population spike field potentials
are taken from the times indicated by the numerals
1 and 2; control left, treated right.
(D–F) Coapplication of Ab1–42 along with AM251
had no additional effect (B, n = 6; (D), 133% ±
3%, (E), 512% ± 56%, (F), 387% ± 39%; p =
0.137, 0.388, and 0.496, respectively. AM251
data in (D–F) are the same data as in (A–C). Insets
for (D) and (E): exemplar fEPSP and population
spike field potentials are taken from the times
indicated by the numerals 1 and 2; control left,
treated right. All error bars and quantification in
this figure reflect mean ± SEM.
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Ab Inhibits Endocannabinoid-Mediated Disinhibitionspike, or E-S potentiation (Figures 5D–5F). Thus, we conclude
that Ab and the cannabinoid system participate in a common
pathway, modulating posttetanic disinhibition to influence the
induction of E-S potentiation. Endocannabinoids produce perite-
tanic disinhibition, while Ab prevents that disinhibition.
While the previous experiments strongly suggest that Ab and
endocannabinoids are acting on a common mechanism, perite-
tanic disinhibition, those experiments do not necessarily prove
that Ab is working directly on the endocannabinoid system to
suppress disinhibition. If, for example, posttetanic disinhibition
required the coordinated action of two different factors, both
necessary but neither sufficient, (with one of these factors being
activation of CB1R), then blockade of either CB1R or that sec-
ond, unspecified Ab-sensitive factor would produce the same
results that we report. We needed an experiment to test whether
Abwas working directly on the endocannabinoid system. There-
fore, we tested whether Ab blocks classical cannabinoid-depen-
dent DSI (Castillo et al., 2012). In Figure 6, spontaneous inhibitory
postsynaptic currents (sIPSCs) were recorded in whole-cell
configuration (Cohen et al., 1992; Doze et al., 1991, 1995). These
IPSCs arise from a combination of quantal synaptic release of
GABA from inhibitory terminals and action potential-dependent
release evoked by the spontaneous action potential discharge
of inhibitory interneurons. Both types of events are mediated
by the neurotransmitter GABA primarily through action on theNeuron 82, 1334–134postsynaptic GABAA receptor (Doze
et al., 1991). DSI was induced by briefly
stepping the holding potential of the py-
ramidal neuron from 60 to 0 mV for a
few seconds and then back to 60 mV(Wilson and Nicoll, 2001). Figure 6A shows an individual neuron
held in voltage clamp at 60 mV, depolarized to 0 VM for 5 s
and then repolarized to the60mV holding potential. DSI lasting
several seconds is apparent as the suppression of the amplitude
of sIPSCs immediately after the depolarization. Figure 6B shows
the average amplitude of sIPSCs in 12 pyramidal neurons, in 1 s
duration bins for 10 s before and 15 s after the depolarization.
Statistically significant DSI occurred in controls, but in the pres-
ence of Ab therewas no significant difference in the spontaneous
IPSCs before and after depolarization. Note that DSI occurred
in less than half of the pyramidal neurons we tested, and we
only applied Ab to those cells where it was detected.
While Ab is clearly working to block the action of endocanna-
binoids as evinced by the blockade of DSI (Figure 6), the mech-
anism of this blockade remains to be elucidated. There are two
major possible mechanisms that may underlie this blockade,
the first being that Ab blocks the production of endocannabi-
noids and the second being that it blocks their action. To differ-
entiate between these possibilities we tested the efficacy of Ab in
blocking the disinhibitory action of an exogenous cannabinoid
agonist. The potent and selective CB1R agonist arachidonylcy-
clopropylamide (ACPA) was bath applied at 20 mM to hippocam-
pal slices, while recording spontaneous IPSCs in CA1 pyramidal
neurons (Figure 7A1). In 9 of 13 experiments, ACPA caused a
marked suppression of the amplitude and apparent frequency5, June 18, 2014 ª2014 Elsevier Inc. 1339
Figure 6. Ab1–42 Blocks Depolarization-Induced Suppression of In-
hibition
(A) Exemplar IPSCs from a CA1 pyramidal neuron recorded in whole-cell
voltage clamp. Depolarization-induced suppression of inhibition (DSI) was
induced with a depolarization (depol.) to 0mV for 5 s. Following this depolari-
zation, spontaneous IPSCs were suppressed for 10–15 s. Application of
Ab1–42 (500 nM) for 15 min largely abolished this suppression of the IPSCs.
(B) The graphs show the average DSI in those neurons that displayed it
and subsequent blockade of DSI by Ab1–42 in those same neurons. The
amplitude of spontaneous IPSCs is shown in 1 s bins for 10 s before and 15 s
after depolarization. The duration of the depolarization ranged from 5–12 s,
but was always the same within each experiment (n = 12). Mean ± SEM,
***p < 0.001, **p% 0.01, *p < 0.05.
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Ab Inhibits Endocannabinoid-Mediated Disinhibitionof the spontaneous IPSCs (with no discernible effect in the other
4 of 13). In the nine experiments where ACPA showed activity
against the spontaneous IPSCs, we subsequently applied Ab
in the continued presence of ACPA. This addition of Ab caused
a recovery of the spontaneous IPSC amplitude to a level not
significantly different from baseline (Figures 7B and 7C). Note
also that when this experiment was repeated in reverse order,
with Ab applied first, followed by application of ACPA, the
agonist-induced suppression of the IPSCs was prevented.
Because these experiment use an exogenous ligand, and thus
bypass physiological endocannabinoid production, they demon-
strate that Ab is working not by reducing production of endocan-
nabinoids, but rather by blocking the CB1R-mediated action of
endocannabinoids. Ab is not, however, exerting this effect by
antagonizing cannabinoid binding to the CB1R, as Ab did not
displace labeled antagonist (3H-Rimonabant, SR141716) from
the receptor in a competition binding assay (Figure S2) (Farrens
et al., 2002). Therefore, Ab is likely working on a mechanism
downstream from ligand binding to the receptor.
DISCUSSION
The literature on the effects of Ab on LTP of hippocampal synap-
tic transmission reveals mixed results. Some laboratories have
reported a robust inhibition of LTP by Ab (Chen et al., 2000;1340 Neuron 82, 1334–1345, June 18, 2014 ª2014 Elsevier Inc.Cullen et al., 1997; Freir et al., 2001; Townsend et al., 2006;
Wang et al., 2002) while others have shown an Ab-mediated
effect occurring under a more restricted set of circumstances
(Gengler et al., 2007; Ro¨nicke et al., 2008; Wang et al., 2004a).
In our experiments, we found that weakly induced LTP was
modestly reduced by application of Ab, while LTP induced by a
strong stimulus was reduced to a lesser extent (Gengler et al.,
2007). Regardless, we established that E-S potentiation is
much more sensitive to Ab than is LTP in our experiments, as it
is profoundly inhibited even when using strong inducing stimuli.
This suggested to us that the more significant action of Abmight
be on the potentiation of the coupling between the EPSP and the
discharge of the soma/axonal action potential.
Importantly, our data support the idea that Ab does not work
directly to inhibit either LTP or E-S potentiation but rather tends
to work indirectly to oppose their induction by limiting the
amount of postsynaptic depolarization during tetanic stimulation
via the mechanism of suppressing peritetanic disinhibition.
Disinhibition would be expected to favor the induction of both
LTP and E-S potentiation (Chevaleyre and Castillo, 2004; Wig-
stro¨m and Gustafsson, 1983, 1985), because postsynaptic sum-
mation of depolarizing EPSPs during the tetanus would be
greater in the absence of synaptic inhibition (see Figure 4C).
By suppressing this disinhibition, thus leaving inhibition intact
during the tetanus, Ab would act to indirectly oppose LTP and
E-S potentiation induction. This is consistent with the fact that,
as we and others before us have shown, Ab impairs LTP when
weakly, but not strongly induced (Gengler et al., 2007). In our
particular experiments, we believe the tetanic induction protocol
utilized is strong enough to provide sufficient postsynaptic depo-
larization in the dendrites to overcome the influence of what is
mostly likely to be somatic inhibition (Alger and Nicoll, 1982),
rendering the presence of Ab mostly irrelevant as far as the
induction of strong LTP of the EPSP is concerned. This idea is
supported by the fact that when using our strong induction pro-
tocol, we observed no increase in LTP with picrotoxin, which is
frequently used to enhance LTP induction (Chevaleyre and Cas-
tillo, 2004; Wigstro¨m and Gustafsson, 1983, 1985) suggesting
that this strongly induced LTP is not sensitive to the influence
of synaptic inhibition (Wigstro¨m and Gustafsson, 1985). Our
data do not address whether different forms of LTP are differen-
tially sensitive to Ab. Several of the prior studies examining the
effect of Ab on LTP used picrotoxin or other GABAergic blockers
without preventing Ab action (Chen et al., 2000; Raymond et al.,
2003; Rowan et al., 2004; Wang et al., 2002, 2004a, 2004b), sug-
gesting that there may be possible secondary mechanism
through which Ab might reduce LTP, such as changes in gluta-
mate release, a decrease in postsynaptic glutamate receptors
or loss of physical synapses (Abramov et al., 2009; Almeida
et al., 2005; Chapman et al., 1999; Freir et al., 2001; Hsieh
et al., 2006; Kamenetz et al., 2003; Shankar et al., 2007; Snyder
et al., 2005; Wei et al., 2010). The induction and/or expression of
E-S potentiation seems more closely tied to synaptic inhibition
(Chavez-Noriega et al., 1989; Daoudal et al., 2002; Tomasulo
et al., 1991; Wigstro¨m and Gustafsson, 1985), and the reduction
in E-S potentiation we observed as a result of picrotoxin appli-
cation (Figure 3) further suggests that this form of plasticity is
expressed at least in large part via a persistent reduction in
Figure 7. Ab1–42 Blocks the Action of an
Exogenous CB1R Agonist
(A1) An exemplar experiment showing the effect of
the CB1R agonist arachidonylcyclopropylamide
(ACPA) on the amplitude of spontaneous inhibi-
tory postsynaptic current (IPSCs) recorded in
whole cell voltage-clamp and the subsequent
blockade of the ACPA effect upon subsequent
addition of Ab1–42.
(A2) Another exemplar experiment where the
drug application was done in the opposite order,
Ab1–42 first, followed by ACPA. Note that Ab1–42
had no effect on spontaneous IPSCs by itself, but
prevented the action of ACPA.
(B) The average effects of ACPA and Ab1–42 in the
nine experiments where Ab was applied (first
three bars). ACPA caused a significant decrease
in IPSP amplitude (*p < 0.01), which recovered to a
value not significantly different frombaseline upon
addition of Ab1–42. Application of ACPA after
Ab1–42 (last three bars) caused no decrease in the
amplitude of spontaneous IPSCs (n = 5 experi-
ments, mean ± SEM, no effect of ACPA in any of
the 5).
(C) Selected traces from the control, ACPA, and
Ab1–42 + ACPA regions of the experiment illus-
trated in (A1), shown at a faster time base to better
illustrate the suppression of IPSP amplitude.
See also Figure S2.
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Ab Inhibits Endocannabinoid-Mediated Disinhibitionsynaptic inhibition. Our data also do not support a role for Ab in
non-inhibition-associated E-S potentiation because the Ab-sen-
sitive portion of E-S potentiation is completely occluded by the
application of picrotoxin in our experiments. We also did not
observe any decrease in basal synaptic transmission when
applying Ab. Note, however, that these previous studies report-
ing Ab-induced downregulation of excitatory synapse number or
function have often relied on chronic elevation of Ab over a signif-
icantly longer period of time using, for example, genetic overex-
pression. Our study is confined to the acute effects of exogenous
Ab applied over a time scale of only tens of minutes. Our data
also suggest a means to explain why LTP is less sensitive to
Ab than is E-S potentiation. Because the Ab-sensitive E-S poten-
tiation induction that we describe here is entirely occluded by the
blockade of GABAA receptor channels, the induction site for that
portion of E-S potentiation is more likely to be perisomatic, as
opposed to the induction site for LTP, which is clearly dendritic
(Alger and Nicoll, 1982; Andersen et al., 1969). If this is theNeuron 82, 1334–134case, then LTP would be less sensitive
to somatic synaptic inhibition than would
E-S potentiation. Indeed, it has been
shown that dendritic inhibition is less
susceptible to DSI than is somatic inhibi-
tion, further supporting this idea (Morish-
ita and Alger, 2001).
Based on our results, we propose
a mechanism for the action of Ab on
hippocampal plasticity that involves the
suppression of cannabinoid-mediated
disinhibition via a blockade of the activityof the CB1 receptor. This suppression of disinhibition leaves
synaptic inhibition intact, thus opposing the depolarization of
the postsynaptic pyramidal neuron during tetanic stimulation of
its presynaptic afferents. As such, any effects that Ab may
have on the induction of E-S potentiation or LTP are indirect.
Tetanic stimulations that are strong enough to overcome the
intact synaptic inhibition will induce full strength LTP, despite
the presence of Ab. Weaker induction protocols will produce
LTP that appears to be Ab-sensitive, because those weaker pro-
tocols cannot produce the sufficient postsynaptic depolarization
that LTP induction requires in the face of intact synaptic inhibi-
tion. E-S potentiation being more closely tied mechanistically
and spatially to somatic synaptic inhibition would be more sen-
sitive to Ab even at higher induction strengths.
The disinhibition that follows tetanic stimulation is transient
and thus exerts a major influence during the induction of E-S
potentiation. The particular tetanic stimulation protocol used
in this study did not produce a large persistent depression of5, June 18, 2014 ª2014 Elsevier Inc. 1341
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Ab Inhibits Endocannabinoid-Mediated Disinhibitioninhibitory transmission (I-LTD) as reported by others using
different inducing stimulus patterns (Chevaleyre and Castillo,
2003, 2004). Even so, our data (Figure 4) show a small trend to
more persistent suppression of the IPSP, which, given the
nonlinear nature of the relationship between the IPSP and pyra-
midal cell excitation, may be sufficient tomaintain the E-S poten-
tiation that we see. This seems even more likely when consid-
ering that preapplication of picrotoxin completely prevented all
Ab-sensitive E-S potentiation from occurring, suggesting that
all of this portion of E-S potentiation is related to synaptic inhibi-
tion as opposed to other factors. Other factors that may act to
maintain the Ab-sensitive portion of E-S potentiation are not
addressed by our experiments. However, we can say they do
not include a change in the resting membrane potential (Fig-
ure 4E) or the properties of nonsynaptic electrical shunts in the
dendrites, because there is no Ab-sensitive E-S potentiation
that survives picrotoxin application. They also do not reflect a
change in the underlying excitatory synaptic potential, because
neither it, nor its potentiation is sufficiently affected by Ab, at
least in cases of strong LTP induction. Possibilities for additional
factors that contribute to the maintenance of E-S potentiation
might include persistent changes in the action potential
threshold of the postsynaptic cell, changes in electrical or
ephaptic coupling of pyramidal cells, or changes in tonic synap-
tic inhibition (Chavez-Noriega et al., 1989). Likewise, our data
indicate that Ab is blocking the activity of cannabinoids through
the CB1R, but that Ab is not acting as a classical receptor antag-
onist. Thus we conclude that Ab antagonizes CB1R activity at
a site downstream from the receptor (Chevaleyre et al., 2007;
Yu et al., 2012).
It is well known from previous work that CB1 receptor block
results in impairment of hippocampal-dependent learning and
memory (see Davies et al., 2002 for review). The mechanism
by which Ab disables the effects of cannabinoids on synaptic
inhibition, and thus disrupts plasticity, may explain learning
and memory deficits in AD that occur in otherwise healthy neural
circuits prior to AD-related neuronal cell death. Changes in
neuronal circuitry of the hippocampus have been reported
long before appearance of the signal sign of Alzheimer’s dis-
ease, amyloid plaques (Hsia et al., 1999), and impaired cannabi-
noid signaling may play a role in that aspect of the neuropa-
thology (Aso et al., 2012; Gowran et al., 2011; Haghani et al.,
2012a, 2012b; Stumm et al., 2013). The present discovery of
an explicit role for Ab in suppressing cannabinoid function eluci-
dates a substrate of Alzheimer’s pathology. Thus, this newfound
knowledge may advance understanding of the causes of
Alzheimer’s symptomatology and open new avenues for thera-
peutic intervention and improvement not only for memory in
the earlier stages of the disease, but for the progression of the
disease itself.
EXPERIMENTAL PROCEDURES
All experiments used acutely prepared transverse hippocampal slices from
male Wistar rats (P25 to P40) recorded in 95% O2/5% CO2 saturated artificial
cerebrospinal fluid (ACSF): 119 mM NaCl, 2.5 mM KCl, 6.0 mM MgSO4,
2.5 mM CaCl2, 1.0 mM NaH2PO4, 26.2 mM NaHCO3, and 11.0 mM glucose)
at room temperature (22C). Note that other studies have reported that work-
ing at similar temperatures does not impair the ability of Ab1–42 to reduce LTP1342 Neuron 82, 1334–1345, June 18, 2014 ª2014 Elsevier Inc.(Kroker et al., 2013; Nomura et al., 2005, 2012; Rammes et al., 2011).
Slices were prepared by standard methods (Madison and Nicoll, 1986). Field
potentials were recorded in the stratum pyramidale and stratum radiatum of
the CA1 area with glass microelectrodes filled with 3M NaCl, having a resis-
tance of 1–2 mOhm. Intracellular recordings of membrane potential were
recorded in CA1 pyramidal cells impaled with glass sharp microelectrodes
filled with 2 M potassium methyl sulfate (ICN Pharmaceuticals), having a resis-
tance of 100–200 mOhm. Both types of glass microelectrode were prepared
on a Sutter Instruments P87 micropipette puller. Schaffer collateral/commis-
sural afferent pathway axons were stimulated at a frequency of 0.033 Hz,
delivering 100 ms shocks through a concentric bipolar model CBABB75
electrode (Frederick Haer) placed in stratum radiatum near the CA2/CA1
border. E-S coupling and potentiation were measured by taking the ratio of
the area of the population spike over the fEPSP rising slope. Because the pop-
ulation spike is a compound action potential, its amplitude can vary with num-
ber of cells firing and the synchrony of their firing. By taking the area of the
spike instead of the amplitude, the measurement becomes the sum total of
the action potentials of all cells that fired during the field spike regardless of
synchrony of firing and is thus a more accurate measure of excitation of the
cell body population than amplitude. Unless otherwise indicated, plasticity
was induced with three 1 s trains of stimuli at 100 Hz at test duration and ampli-
tude and an intertrain interval of 15 s. In experiments where stimulus-evoked
IPSPs were recorded, the stimulus and the tetanus was identical to that
used in field experiments. Data were acquired with an Axoclamp 2-A amplifier,
amplified with a Brownlee Precision model 200 amplifier, and digitized with a
National Instruments analog-to-digital converter, using LabView software.
Data were analyzed with a custom-written LabView-based program (written
by Eric Schiable and Paul Pavlidis). Spontaneous IPSC experiments were
acquired on an Axopatch 2A and Axon Instruments Model 1322A A-to-D
converter using PClamp 10 software. Statistical significance of LTP experi-
ments was determined by 2-way ANOVA for repeated-measures over
the entire posttetanus period (0–45 min). Where the significance of individual
pairwise comparisons was made, Student’s t test was used. Picrotoxin
and AM251 were obtained from Tocris Cookson. All procedures in this
paper were carried out in strict accordance with a protocol approved by the
Stanford University School of Medicine Administrative Panel on Laboratory
Animal Care (APLAC).
Picrotoxin Experiments
Picrotoxin, where used, was applied for 1 hr prior to application of tetanic stim-
ulation. Picrotoxin alone caused an increase in the amplitude and area of the
population spike and thus in E-S coupling (Wigstro¨m and Gustafsson, 1985).
The stimulus strength was adjusted to give a baseline population spike as
close as possible in amplitude and area to those in the nonpicrotoxin experi-
ments of Figure 1. The prior addition of picrotoxin had no effect on the amount
of LTP of the fEPSP (Figure 3A), in agreement with previous studies on the
effects of GABAA-receptor blockade on strongly-induced LTP (Wigstro¨m
and Gustafsson, 1985), while reducing E-S potentiation.
DSI and Spontaneous IPSCs
We recorded spontaneous inhibitory synaptic currents in whole-cell voltage
clamp according to the methods previously described (Cohen et al., 1992;
Doze et al., 1991, 1995), using a Cs-sulfate-based internal solution with
elevated chloride and in the presence of bath-applied NBQX (10 mM) and
AP-5 (50 mM). The contents of the whole-cell electrode internal solution was
(mM): 100 CsCH3SO3, 60 CsCl, 5 QX-314 chloride, 10 HEPES, 0.2 EGTA, 1
MgCl2, 1 Mg-ATP, and 0.3 Na3GTP (pH 7.3, 275 mOsM). DSI was induced
by stepping the holding potential of the postsynaptic pyramidal neuron from
60 mV to 0 mV for a period ranging from 5–12 s and then repolarizing it
to 60 mV. DSI was recorded in control ACSF, and then after a 10–15 min
application of Ab at 500 nM. In each individual cell, the depolarization was
held for the same duration before and after application of Ab. In spontaneous
IPSC experiments, we do not quantify the effect of ACPA or Ab on the
frequency of spontaneous IPSCs because while it appeared to be reduced,
this effect is seen as secondary to the decrease in amplitude (i.e., the decrease
in amplitude causes the smaller events to drop below detection threshold,
resulting in an apparent, but not actual decrease in frequency). Spontaneous
Neuron
Ab Inhibits Endocannabinoid-Mediated DisinhibitionIPSC amplitude was analyzed using Synaptosoft software (http://Synaptosoft.
com). ACPA in Tocrisolve 100 (Tocris Bioscience) was applied in the bath at
20 mM.
Preparation of Ab
Synthetic Ab(1–42) was supplied by Elan Pharmaceuticals and stock solu-
tions were prepared as described in Wang et al. (2008), prepared at 50 mM
in 0.1% NH4OH, aliquoted, and frozen. Vials were thawed and diluted to
500 nM in ACSF and applied to slices by superfusion. The vehicle for all Ab
experiments was ACSF with a final concentration of 0.001% NH4OH. For all
AM251 experiments, vehicle was ACSF with 0.01% DMSO. For experiments
where both were applied simultaneously, the vehicle contained both NH4OH
and DMSO.
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